WELCOME TO THE ITOC5
THE 5TH LEADING INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE IN EUROPE
The Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer (SITC) has the great pleasure to invite you to take part in the 5th Immunotherapy of Cancer Conference (ITOC5) – the leading International conference in Europe providing a global platform for translational research in the field of immuno-oncology.
The ITOC series of conferences is the premier meeting for scientific exchange, networking and education within the cancer immunotherapy field.
ITOC5 will reunite preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry in a forum to discuss early clinical drug developments and address the unique challenges
ITOC conferences are renowned for the highly scientific character of its lectures. And the previous conferences surpassed all expectations in terms of attendance and scientific outcome. The programme will focus on the latest challenges of translational research with a special emphasis on innovations in combination therapy, immune-monitoring and biomarker development.
Join us in Berlin, Germany on 19 – 21 March 2018 to help push further the opportunities that will ultimately aid in revolutionising the way cancer is treated.
Help us spread the world, download and share this ‘Save the date‘!
|Registration opens||September 1, 2017|
|Abstract submission opens||September 1, 2017|
|Abstract submission closes||December 1, 2017|
|Early rate registration closes||December 15, 2017|
|Regular rate registration closes||March 9, 2018|
|ITOC5 Conference||March 19 – 21, 2018|
More information soon on:
- About Berlin
- CME Credits & Compliance
- Networking Events
- Satellite Symposium
- Scientific Committee
- Scientific Programme
Join the discussion on Twitter by using #ITOC5 !